Invoking a strategy previously used to identify disease-relevant T cells in inflammatory arthritis20,30 and cancer31, a subset of highly clonally expanded and CSF-enriched CD8+ T cells was identified that had the highest frequencies in MS/CIS participants. The gene discussed is CD8A; the disease is in situ carcinoma.